Amino acids and peptides. XIV. Laminin related peptides and their inhibitory effect on experimental metastasis formation. 1991

K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
Faculty of Pharmaceutical Sciences, Kobe-Gakuin University, Japan.

Inhibitory effects of synthetic laminin related peptides on experimental metastasis formation in mice were examined. Of the synthetic peptides, YIGSRG-[amino-poly(ethylene glycol)] hybrid exhibited the most potent inhibitory effect on the metastasis of B16 melanoma BL6.

UI MeSH Term Description Entries
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008546 Melanoma, Experimental Experimentally induced tumor that produces MELANIN in animals to provide a model for studying human MELANOMA. B16 Melanoma,Melanoma, B16,Melanoma, Cloudman S91,Melanoma, Harding-Passey,Experimental Melanoma,Experimental Melanomas,Harding Passey Melanoma,Melanomas, Experimental,B16 Melanomas,Cloudman S91 Melanoma,Harding-Passey Melanoma,Melanoma, Harding Passey,Melanomas, B16,S91 Melanoma, Cloudman
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
February 1998, Chemical & pharmaceutical bulletin,
K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
January 1973, Journal of the Chemical Society. Perkin transactions 1,
K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
July 1998, Biochemical and biophysical research communications,
K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
May 1993, Chemical & pharmaceutical bulletin,
K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
March 1993, Chemical & pharmaceutical bulletin,
K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
January 1957, Bollettino della Societa italiana di biologia sperimentale,
K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
October 1966, Justus Liebigs Annalen der Chemie,
K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
December 1989, Thrombosis research,
K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
November 1987, Science (New York, N.Y.),
K Kawasaki, and M Namikawa, and T Murakami, and T Mizuta, and Y Iwai, and T Hama, and T Mayumi
January 1969, Life sciences and space research,
Copied contents to your clipboard!